Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma.

Volume:Pages
31(1):50-63
Site
Toronto
Pubmed id
28073004
Authors

Veschi V, Liu Z, Voss TC, Ozbun L, Gryder B, Yan C, Hu Y, Ma A, Jin J, Mazur SJ, Lam N, Souza BK, Giannini G, Hager GL, Arrowsmith CH, Khan J, Appella E, Thiele CJ

DOI
10.1016/j.ccell.2016.12.002
Journal
Cancer Cell
Publication Date
2017-1-9
Year
2017
N Publication Date
PI authors
Arrowsmith
Validated
Y